CClinicalTrials.gg
CompletedNCT06153628Updated May 11, 2025

The Effect of Virtual Reality Glasses on Anxiety Level and Breast Milk Amount

An interventional study of Virtual reality glasses in Anxiety and Amount of Breast Milk, sponsored by Mersin University. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-11.

Sponsored by Mersin University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Pain, anxiety, nausea, vomiting, etc. In coping with symptoms, virtual reality glasses are recommended as a distraction application. The study was planned to examine the effect of virtual reality glasses applied to mothers whose babies were in the neonatal intensive care unit, on the level of anxiety and the amount of breast milk.

Read the detailed description

Although milk is expressed early and frequently, milk volume and milk production may be lower in some mothers in the first few weeks.For this reason, pharmacological and non-pharmacological methods have been focused on to increase prolactin secretion and breast milk production in mothers with premature babies. It is emphasized that practices such as breast massage, hot application, nutrition and fluid consumption of the mother, thinking about her baby or looking at her picture, and psychological relaxation during milk expression with a pump increase the amount of milk. It is thought that the mother's stress and anxiety negatively affect the amount of breast milk in preterm births, and that methods that provide relaxation and relief will contribute to breast milk production by reducing stress and anxiety. Pain, anxiety, nausea, vomiting, etc. In coping with symptoms, virtual reality glasses are recommended as a distraction application.

02

Conditions studied

  • Anxiety
  • Amount of Breast Milk

Browse trials for

Keywords

  • Anxiety
  • Breast milk
  • Breastfeeding
  • Premature
  • Virtual reality glasses
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Mersin University is the lead sponsor of 173 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Are between the ages of 18-45,
  • Those who gave birth at a gestational age of 30 weeks or more,
  • whose baby is still in intensive care,
  • whose baby has started breastfeeding,
  • Giving breast milk to her baby by expressing,
  • Not using any medication that will affect milk supply,
  • Not diagnosed with a psychiatric disease that will affect breastfeeding in the postpartum period,
  • Those who have not had any breast-related surgery before,
  • Understands Turkish and can communicate,
  • Mothers who sign the Informed Volunteer Consent Form will be included in the research.

Exclusion criteria

Exclusion Criteria:

  • Those who are younger than 18 years of age or older than 45 years of age,
  • The gestational age is less than 30 weeks,
  • whose baby was discharged from intensive care,
  • whose baby has not started breastfeeding,
  • Those who do not express breast milk to their babies,
  • Using medication that will affect milk supply,
  • Diagnosed with a psychiatric disease that will affect breastfeeding in the postpartum period,
  • Have had any breast-related surgery before,
  • Cannot communicate in Turkish,
  • Mothers who do not sign the Informed Volunteer Consent Form will not be included in the research.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Virtual reality glasses

    First of all, the "State Anxiety Inventory" will be applied to all women (60 women).Then, milk will be expressed from both breasts once a day (10:00) for the first 3 days and the amount of milk expressed will be recorded in the "Breast Milk Amount Tracking Form". After the first 3 days, all women will be relaxed by watching virtual reality glasses (10 minutes) once a day (10:00 in the morning) for 3 days, and the "State Anxiety Inventory" will be applied at the end of the video. Then, milk will be expressed from both breasts and recorded in the "Breast Milk Amount Tracking Form".

    Other: Virtual reality glasses

Interventions

  • OtherVirtual reality glasses

    Videos consisting of nature and undersea images will be played through virtual reality glasses, which the woman wants to watch and can change whenever she wants.

06

What researchers measure

Primary outcomes

  1. State-Anxiety Inventory

    In the Likert-type scale consisting of 20 items, the items are numbered from 1 to 4 (1 means "not at all" and 4 means "completely").The scores obtained from the scale vary between 20 and 80 and there are direct (straight) and reversed expressions in the scale.

    Time frame: Up to 3 Months

Secondary outcomes

  1. Breast Milk Quantity Monitoring Form

    It is a form consisting of 3 parts developed by the researcher to record information about milking date, milking time and milk amount.

    Time frame: Up to 3 Months

07

Study locations

1 site
  • Mersin University
    Mersin, Turkey
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06153628
Lead sponsor
Mersin University
Responsible party
Aslı EKER (Dr.Lecturer, Mersin University) — Principal investigator
First posted
Dec 1, 2023
Start date
Nov 2, 2023
Primary completion
Apr 10, 2024
Completion
Jun 15, 2024
Last update
May 11, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion